EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSPLAG00000014783
Gene Symbol: TAAR1
1 Cross references
417 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPLAG00000015788
Gene Symbol: TAAR1
2 Cross references
378 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPLAG00000008389
Gene Symbol: TAAR1
3 Cross references
386 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSPLAG00000003389
Gene Symbol: LOC106938010
3 Cross references
199 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSPLAG00000015090
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSPLAG00000009921
Gene Symbol: LOC106959120
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSPLAG00000008937
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSPLAG00000017013
Gene Symbol: TUBA1C
3 Cross references
52 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPLAG00000013090
Gene Symbol: TUBA4A
4 Cross references
109 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSPLAG00000015938
Gene Symbol: LOC106958014
2 Cross references
170 Possible Orthologues:

Tubulin Alpha-4 Chain-Like

Ensembl ID : ENSPLAG00000013121
Gene Symbol: LOC106962470
2 Cross references
109 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSPLAG00000009518
Gene Symbol: TUBB4B
4 Cross references
11 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).